Autor(es): Roxo, Maria Inês ; Pepe, Bruno ; Birne, Rita
Data: 2023
Identificador Persistente: http://hdl.handle.net/10362/176493
Origem: Repositório Institucional da UNL
Assunto(s): Nephrology
Autor(es): Roxo, Maria Inês ; Pepe, Bruno ; Birne, Rita
Data: 2023
Identificador Persistente: http://hdl.handle.net/10362/176493
Origem: Repositório Institucional da UNL
Assunto(s): Nephrology
Funding Information: R. Birne reports the following: employed by Diaverum; research funding from Gilead, Bayer, and Boehringer; member in advisory board of Bayer and Boehringer; and member of the speakers bureau of AstraZeneca, Bayer, Boehringer, MSD and Bial. M. Roxo reports the following: employed by Fresenius Medical Care.